Increased endogenous estrogen synthesis leads to the sequential induction of prostatic inflammation (prostatitis) and prostatic pre-malignancy

American Journal of Pathology

Volumn 175, Issue 3, 2009, Pages 1187-1199

  Ellem, Stuart J ^a,c   Wang, Hong ^a   Poutanen, Matti ^b   Risbridger, Gail P ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF TURKU   (Finland)

^c NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; ESTRADIOL; ESTROGEN; TESTOSTERONE;

ANIMAL EXPERIMENT; ARTICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; ESTROGEN SYNTHESIS; HUMAN; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MAST CELL; MEDIATOR; MORBIDITY; MOUSE; NEUTROPHIL; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRECANCER; PRIORITY JOURNAL; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATITIS; PROTEIN EXPRESSION; PUBERTY; RADIOIMMUNOASSAY; T LYMPHOCYTE; TESTOSTERONE BLOOD LEVEL;

EID: 70349229310     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.081107     Document Type: Article

References (56)

1. Vykhovanets EV, Resnick MI, MacLennan GT, Gupta S: Experimental rodent models of prostatitis: limitations and potential. Prostate Cancer Prostatic Dis 2007, 10:15-29 (Pubitemid 46358907)
2. Collins MM, Stafford RS, O'Leary MP, Barry MJ: How common is prostatitis? A national survey of physician visits. J Urol 1998, 159:1224-1228
3. De Marzo AM, Marchi VL, Epstein JI, Nelson WG: Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol 1999, 155:1985-1992
4. Palapattu GS, Sutcliffe S, Bastian PJ, Platz EA, De Marzo AM, Isaacs WB, Nelson WG: Prostate carcinogenesis and inflammation: emerging insights. Carcinogenesis 2005, 26:1170-1181 (Pubitemid 41417894)
5. Balkwill F, Mantovani A: Inflammation and cancer: Back to Virchow? Lancet 2001, 357:539-545
6. Strickler HD, Goedert JJ: Sexual behavior and evidence for an infectious cause of prostate cancer. Epidemiol Rev 2001, 23:144-151
7. Kirby RS, Lowe D, Bultitude MI, Shuttleworth KE: Intra-prostatic urinary reflux: an aetiological factor in abacterial prostatitis. Br J Urol 1982, 54:729-731 (Pubitemid 13179611)
8. Naslund MJ, Strandberg JD, Coffey DS: The role of androgens and estrogens in the pathogenesis of experimental nonbacterial prostatitis. J Urol 1988, 140:1049-1053
9. Harris MT, Feldberg RS, Lau KM, Lazarus NH, Cochrane DE: Expression of proinflammatory genes during estrogen-induced inflammation of the rat prostate. Prostate 2000, 44:19-25
10. Bianco JJ, McPherson SJ, Wang H, Prins GS, Risbridger GP: Transient neonatal estrogen exposure to estrogen-deficient mice (aromatase knockout) reduces prostate weight and induces inflammation in late life. Am J Pathol 2006, 168:1869-1878
11. Prins GS, Huang L, Birch L, Pu Y: The role of estrogens in normal and abnormal development of the prostate gland. Ann NY Acad Sci 2006, 1089:1-13 (Pubitemid 47092064)
12. Prins GS, Birch L, Couse JF, Choi I, Katzenellenbogen B, Korach KS: Estrogen imprinting of the developing prostate gland is mediated through stromal estrogen receptor alpha: studies with alphaERKO and betaERKO mice. Cancer Res 2001, 61:6089-6097 (Pubitemid 32762544)
13. Coussens LM, Werb Z: Inflammation and cancer. Nature 2002, 420:860-867
14. Kuper H, Adami HO, Trichopoulos D: Infections as a major preventable cause of human cancer. J Intern Med 2000, 248:171-183 (Pubitemid 30693788)
15. Dennis LK, Dawson DV: Meta-analysis of measures of sexual activity and prostate cancer. Epidemiology 2002, 13:72-79 (Pubitemid 34031513)
16. Shappell SB, Thomas GV, Roberts RL, Herbert R, Ittmann MM, Rubin MA, Humphrey PA, Sundberg JP, Rozengurt N, Barrios R, Ward JM, Cardiff RD: Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee. Cancer Res 2004, 64:2270-2305
17. Elkahwaji JE, Zhong W, Hopkins WJ, Bushman W: Chronic bacterial infection and inflammation incite reactive hyperplasia in a mouse model of chronic prostatitis. Prostate 2007, 67:14-21 (Pubitemid 46013463)
18. Bernoulli J, Yatkin E, Talvitie EM, Santti R, Streng T: Urodynamic changes in a noble rat model for nonbacterial prostatic inflammation. Prostate 2007, 67:888-899 (Pubitemid 46828943)
19. Li X, Nokkala E, Yan W, Streng T, Saarinen N, Warri A, Huhtaniemi I, Santti R, Makela S, Poutanen M: Altered structure and function of reproductive organs in transgenic male mice overexpressing human aromatase. Endocrinology 2001, 142:2435-2442 (Pubitemid 32475760)
20. Almahbobi G, Hedwards S, Fricout G, Jeulin D, Bertram JF, Risbridger GP: Computer-based detection of neonatal changes to branching morphogenesis reveals different mechanisms of and predicts prostate enlargement in mice haplo-insufficient for bone morphogenetic protein 4. J Pathol 2005, 206:52-61 (Pubitemid 40613434)
21. McPherson S, Wang H, Jones M, Pedersen J, Iismaa T, Wreford N, Simpson E, Risbridger G: Elevated androgens and prolactin in aromatase deficient (ArKO) mice cause enlargement but not malignancy of the prostate gland. Endocrinology 2001, 142:2458-2467 (Pubitemid 32473102)
22. Bianco JJ, Handelsman DJ, Pedersen JS, Risbridger GP: Direct response of the murine prostate gland and seminal vesicles to estradiol. Endocrinology 2002, 143:4922-4933
23. Cancilla B, Jarred RA, Wang H, Mellor SL, Cunha GR, Risbridger GP: Regulation of prostate branching morphogenesis by activin a and follistatin. Dev Biol 2001, 237:145-158 (Pubitemid 32844312)
24. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C[T]) method. Methods 2001, 25:402-408 (Pubitemid 34164012)
25. Ellem SJ, Schmitt JF, Pedersen JS, Frydenberg M, Risbridger GP: Local aromatase expression in human prostate is altered in malignancy. J Clin Endocrinol Metab 2004, 89:2434-2441 (Pubitemid 38619887)
26. Risbridger G, Wang H, Young P, Kurita T, Wang YZ, Lubahn D, Gustafsson JA, Cunha G, Wong YZ: Evidence that epithelial and mesenchymal estrogen receptor-alpha mediates effects of estrogen on prostatic epithelium. Dev Biol 2001, 229:432-442 (Pubitemid 32108703)
27. Cunha GR, Donjacour A: Stromal-epithelial interactions in normal and abnormal prostatic development. Prog Clin Biol Res 1987, 239:251-272
28. Cunha GR, Young P, Higgins SJ, Cooke PS: Neonatal seminal vesicle mesenchyme induces a new morphological and functional phenotype in the epithelia of adult ureter and ductus deferens. Development 1991, 111:145-158 (Pubitemid 21900212)
29. Day KC, McCabe MT, Zhao X, Wang Y, Davis JN, Phillips J, Von Geldern M, Ried T, KuKuruga MA, Cunha GR, Hayward SW, Day ML: Rescue of embryonic epithelium reveals that the homozygous deletion of the retinoblastoma gene confers growth factor independence and immortality but does not influence epithelial differentiation or tissue morphogenesis. J Biol Chem 2002, 277:44475-44484 (Pubitemid 36157882)
30. McPherson SJ, Ellem SJ, Simpson ER, Patchev V, Fritzemeier KH, Risbridger GP: Essential role for estrogen receptor beta in stromal-epithelial regulation of prostatic hyperplasia. Endocrinology 2007, 148:566-574 (Pubitemid 46143161)
31. Ghadjar P, Loddenkemper C, Coupland SE, Stroux A, Noutsias M, Thiel E, Christoph F, Miller K, Scheibenbogen C, Keilholz U: Chemokine receptor CCR6 expression level and aggressiveness of prostate cancer. J Cancer Res Clin Oncol 2008, 134:1181-1189
32. Lu Y, Cai Z, Xiao G, Liu Y, Keller ET, Yao Z, Zhang J: CCR2 expression correlates with prostate cancer progression. J Cell Biochem 2007, 101:676-685 (Pubitemid 46698852)
33. Vaday GG, Peehl DM, Kadam PA, Lawrence DM: Expression of CCL5 (RANTES) and CCR5 in prostate cancer. Prostate 2006, 66:124-134 (Pubitemid 43191234)
34. Pylkkanen L, Santti R, Newbold R, McLachlan JA: Regional differences in the prostate of the neonatally estrogenized mouse. Prostate 1991, 18:117-129
35. Stoker TE, Robinette CL, Cooper RL: Perinatal exposure to estrogenic compounds and the subsequent effects on the prostate of the adult rat: evaluation of inflammation in the ventral and lateral lobes. Reprod Toxicol 1999, 13:463-472
36. Risbridger G, Frydenberg M: Endocrinology of Prostate Cancer. Edited by LJD Groot. Philadelphia PA, W.B. Sanders, 2004, p. 112-131
37. Hill P, Garbaczewski L, Walker AR: Age, environmental factors and prostatic cancer. Med Hypotheses 1984, 14:29-39 (Pubitemid 15195144)
38. de Jong FH, Oishi K, Hayes RB, Bogdanowicz JF, Raatgever JW, van der Maas PJ, Yoshida O, Schroeder FH: Peripheral hormone levels in controls and patients with prostatic cancer or benign prostatic hyperplasia: results from the Dutch-Japanese case-control study. Cancer Res 1991, 51:3445-3450
39. Ricke WA, McPherson SJ, Bianco JJ, Cunha GR, Wang Y, Risbridger GP: Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling. FASEB J 2008, 22:1512-1520 (Pubitemid 351656791)
40. Zaitsu M, Narita S, Lambert KC, Grady JJ, Estes DM, Curran EM, Brooks EG, Watson CS, Goldblum RM, Midoro-Horiuti T: Estradiol activates mast cells via a non-genomic estrogen receptor-alpha and calcium influx. Mol Immunol 2007, 44:1977-1985 (Pubitemid 44827248)
41. Li X, Strauss L, Kaatrasalo A, Mayerhofer A, Huhtaniemi I, Santti R, Makela S, Poutanen M: Transgenic mice expressing p450 aromatase as a model for male infertility associated with chronic inflammation in the testis. Endocrinology 2006, 147:1271-1277 (Pubitemid 43244360)
42. Saperas E: The role of mast cells in gastrointestinal inflammation. Gastroenterology 1996, 110:1656-1658 (Pubitemid 26134105)
43. Dumont N, Lepage K, Cote CH, Frenette J: Mast cells can modulate leukocyte accumulation and skeletal muscle function following hindlimb unloading. J Appl Physiol 2007, 103:97-104 (Pubitemid 47092281)
44. Cote CH, Tremblay MH, Duchesne E, Lapoite BM: Inflammation-induced leukocyte accumulation in injured skeletal muscle: role of mast cells. Muscle Nerve 2008, 37:754-763 (Pubitemid 351821903)
45. Carlos D, de Souza Junior DA, de Paula L, Jamur MC, Oliver C, Ramos SG, Silva CL, Faccioli LH: Mast cells modulate pulmonary acute inflammation and host defense in a murine model of tuberculosis. J Infect Dis 2007, 196:1361-1368
46. Wershil BK, Furuta GT, Wang ZS, Galli SJ: Mast cell-dependent neutrophil and mononuclear cell recruitment in immunoglobulin E-induced gastric reactions in mice. Gastroenterology 1996, 110:1482-1490
47. Wang Y, Thorlacius H: Mast cell-derived tumour necrosis factor-alpha mediates macrophage inflammatory protein-2-induced recruitment of neutrophils in mice. Br J Pharmacol 2005, 145:1062-1068 (Pubitemid 43079978)
48. von Stebut E, Metz M, Milon G, Knop J, Maurer M: Early macrophage influx to sites of cutaneous granuloma formation is dependent on MIP-1alpha/beta released from neutrophils recruited by mast cell-derived TNFalpha. Blood 2003, 101:210-215 (Pubitemid 36025910)
49. Nakae S, Suto H, Iikura M, Kakurai M, Sedgwick JD, Tsai M, Galli SJ: Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J Immunol 2006, 176:2238-2248 (Pubitemid 43201671)
50. Aydin O, Dusmez D, Cinel L, Doruk E, Kanik A: Immunohistological analysis of mast cell numbers in the intratumoral and peritumoral regions of prostate carcinoma compared to benign prostatic hyperplasia. Pathol Res Pract 2002, 198:267-271 (Pubitemid 34495573)
51. Nonomura N, Takayama H, Nishimura K, Oka D, Nakai Y, Shiba M, Tsujimura A, Nakayama M, Aozasa K, Okuyama A: Decreased number of mast cells infiltrating into needle biopsy specimens leads to a better prognosis of prostate cancer. Br J Cancer 2007, 97:952-956 (Pubitemid 47519307)
52. Hieshima K, Imai T, Opdenakker G, Van Damme J, Kusuda J, Tei H, Sakaki Y, Takatsuki K, Miura R, Yoshie O, Nomiyama H: Molecular cloning of a novel human CC chemokine liver and activation-regulated chemokine (LARC) expressed in liver. Chemotactic activity for lymphocytes and gene localization on chromosome 2. J Biol Chem 1997, 272:5846-5853 (Pubitemid 27102418)
53. Streng T, Li X, Lehtoranta M, Makela S, Poutanen M, Talo A, Tekmal RR, Santti R: Infravesical obstruction in aromatase over expressing transgenic male mice with increased ratio of serum estrogen-to-androgen concentration. J Urol 2002, 168:298-302 (Pubitemid 34649382)
54. Litwin MS, McNaughton-Collins M, Fowler FJ, Jr., Nickel JC, Calhoun EA, Pontari MA, Alexander RB, Farrar JT, O'Leary MP: The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol 1999, 162:369-375
55. McNaughton-Collins M, Joyce GF, Wise M, Pontari M: Urologic Diseases in America. National Institutes of Health, 2007, p. 11-41
56. Miller LJ, Fischer KA, Goralnick SJ, Litt M, Burleson JA, Albertsen P, Kreutzer DL: Interleukin-10 levels in seminal plasma: implications for chronic prostatitis-chronic pelvic pain syndrome. J Urol 2002, 167:753-756 (Pubitemid 34074579)